Clinical Trial Update: Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carfilzomib, lenalidomide, and dexamethasone before and after stem cell transplant in newly diagnosed multiple myeloma; trial completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Decadron (Dexamethasone)
• Kyprolis (carfilzomib)
• Revlimid (lenalidomide)

Snippet

Sponsor: University of Chicago | Conditions: Stage I Multiple Myeloma, Stage II Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2022-09-23